Medical Patent News

RSS

LifeSync to sublicense patent portfolio to Triage Wireless

LifeSync Corporation, a wholly owned subsidiary of GMP Companies, Inc., announced it has entered into a non-exclusive sublicense with Triage Wireless Inc. for LifeSync's patent portfolio associated with the digital, wireless communication of patient vital signs.

23 Apr 2008

Signalife awarded new U.S. patent for method to monitor heartbeats

Signalife, Inc. has announced that the United States Patent and Trademark Office has awarded the Company a new and important patent entitled "System For, And Method Of, Monitoring Heartbeats Of A Patient". The patent, which covers 37 claims, will enhance the Company's ability to develop new proprietary products.

23 Apr 2008

StemCells, Inc. granted U.S. patent covering composition of neural stem cells derived from any tissue source

StemCells, Inc. announced today that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,361,505 with broad claims covering human neural stem cells derived from any tissue source, including embryonic, fetal, juvenile, or adult tissue. The ‘505 patent is exclusively licensed to StemCells.

23 Apr 2008

St. Jude Medical awarded U.S. patent for neurostimulation therapy for depression

St. Jude Medical, Inc. has announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25.

21 Apr 2008

VNUS Medical Technologies receives 'notice of allowability' for endovenous laser products patents

VNUS Medical Technologies, Inc. has announced that the company has received a Notice of Allowability by the U.S. Patent & Trademark Office for a patent application that is a continuation of one of the three patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products.

18 Apr 2008

Biomoda granted 'notice of allowance' for U.S. patent protection for additional IP

Biomoda, Inc., a development stage medical diagnostics company, announced it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its invention directed to the "Method for Prognosing Response to Cancer Therapy with 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine."

18 Apr 2008

Baxter International, Inc. wins patent infringement case

Baxter International, Inc. has won a long-running battle in a patent infringement suit ( Fresenius USA, Inc. et al v. Baxter International Inc. et al. ) against Fresenius Medical Care involving Fresenius ' Number One - selling hemodialysis machine in the United States.

From Baxter International Inc. 7 Apr 2008

Virtual telemicroscope awarded patent

After nearly ten years of research and development, scientists at SUNY Downstate Medical Center in Brooklyn and Peking University in Beijing were awarded a United States patent for their virtual telemicroscope.

31 Mar 2008

U.S. PTO reexamining Lumenis patents

Alma Lasers Ltd., a global leader in aesthetic laser, light-based, and radiofrequency systems, announces important developments in its patent dispute with Lumenis Ltd., which is being litigated in the United States District Court in Chicago, IL. Alma reports that: (1) the U.S. Patent and Trademark Office in Alexandria VA ("PTO") has decided to reexamine all seven of Lumenis's patents that are at issue in the litigation, and (2) the Court has stayed the litigation, pending reexamination of the patents.

From Lumenis Inc. 28 Mar 2008

New online stem cell patent database

StemCellPatents.com, an organization dedicated to the advancement of stem cell commercialization, has announced the launch of its newly re-designed free database covering US issued patents dealing with stem cells.

28 Mar 2008

U.S. Patent Office confirms validity of Osteotech's U.S. patent on mixtures of a radiolucent material

Osteotech, Inc. ( NASDAQ:OSTE ) , a leader in the emerging field of biologic solutions for regenerative medicine, announced today that the United States Patent and Trademark Office has confirmed the validity of its U.S. Patent No. 5,676,146.

25 Mar 2008

Bioheart awarded patent for heart repair method

Bioheart, Inc. has announced that it has been awarded U.S. Patent #: 7341062 (J. Chachques and H. Leonhardt) for a method to repair damaged myocardium (heart tissue) by a combination of cell transplantation and electrostimulation.

18 Mar 2008

DuPont no. 1 innovator in chemical and biotech patents

DuPont has achieved top rankings in science and patent strength according to several leading indicators published by The Patent Board and Nature Biotechnology.

13 Mar 2008

Miniature chemical detection device awarded U.S. patent

The U.S. Patent Office has awarded Dr. George Radziszewski a U.S. Patent (No. 7,342,664) for his revolutionary ChemiD Mini Lab, a miniature device that will identify chemical compounds on demand.

11 Mar 2008

Anadis licenses antibody technologies from ImmuCell

Anadis Limited, an Australian-based biotechnology company focused on milk derived polyclonal antibodies and other milk-derived bioactives, announced today that it had signed a final agreement with ImmuCell Corporation, a biotechnology company headquartered in Portland, Maine, USA.

11 Mar 2008

Jivan Biologics awarded US patent for splice array analysis

Jivan Biologics Inc., a privately held corporation located in Berkeley, CA, has been awarded US Patent #7,340,349, "Method and System for Identifying Splice Variants of a Gene."

10 Mar 2008

Barr Pharmaceuticals announces favorable ruling in Yasmin patent case

Barr Pharmaceuticals, Inc. has announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive.

4 Mar 2008

Imaging Dynamics Company receives patent on dual energy imaging technology

Imaging Dynamics Company Ltd has announced that it was awarded the patent for a dual energy optically coupled digital radiography system.

28 Feb 2008

New Alzheimer's patent by Affiris

Affiris GmbH has secured another Europe-wide patent for an innovative method of treating Alzheimer's disease. This new blood-cleansing method is similar to dialysis and is designed to reduce the amount of harmful protein deposits in the brain. It is based on the AFFITOME technology established by Affiris, which was patented in October 2007 for an Alzheimer's vaccine.

27 Feb 2008

Barr confirms Avodart patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by GlaxoSmithKline in connection with its Avodart(R) (dutasteride) soft gelatin capsules, 0.5mg.

27 Feb 2008